Coalition for PET Drugs

SNMMI continues to be an active participant in the Coalition for PET Drugs.  The Coalition's purpose is to help the PET community understand requirements related to the implementation of 21 CFR part 212 and the submission process for PET NDAs or ANDAs, and to make a positive impact on the overall implementation process through interaction with the FDA.

Please visit the Coalition website for the most up-to-date information on Part 212: